3.20
price down icon1.84%   -0.06
after-market Handel nachbörslich: 3.16 -0.04 -1.25%
loading

Finanzdaten der Dare Bioscience Inc-Aktie (DARE)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
99.49%
0.0093
1.8079 1.00 - -
Operating Expenses
13.58%
6.0318
6.9793 9.3964 8.9894 8.3826
Benefits Costs and Expenses
100.00%
-
32.97 - - -
Costs And Expenses
2.69%
6.0318
6.1985 9.3964 - -
Operating Income/Loss
16.46%
-6.0225
-5.1715 -8.3964 -8.9894 -8.3826
Income/Loss From Continuing Operations Before Tax
100.03%
0.0093
-31.16 1.00 -8.7622 -8.0425
Income/Loss From Continuing Operations After Tax
33.63%
-6.7554
-5.0552 -8.2991 -8.7622 -8.0425
Net Income/Loss
33.57%
-6.7554
-5.0576 -8.2991 -8.7622 -8.0425
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
122.29K%
100.51
0.0821 91.05 86.40 85.52
Diluted Average Shares
122.29K%
100.51
0.0821 91.05 86.40 85.52
Basic Earnings Per Share
16.67%
-0.07
-0.06 -0.09 -0.10 -0.09
Diluted Earnings Per Share
16.67%
-0.07
-0.06 -0.09 -0.10 -0.09
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):